ES2185942T3 - Uso de la l-lisina en el tratamiento de la perdida del cabello. - Google Patents

Uso de la l-lisina en el tratamiento de la perdida del cabello.

Info

Publication number
ES2185942T3
ES2185942T3 ES97925169T ES97925169T ES2185942T3 ES 2185942 T3 ES2185942 T3 ES 2185942T3 ES 97925169 T ES97925169 T ES 97925169T ES 97925169 T ES97925169 T ES 97925169T ES 2185942 T3 ES2185942 T3 ES 2185942T3
Authority
ES
Spain
Prior art keywords
pct
treatment
lisine
hair
loss
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97925169T
Other languages
English (en)
Inventor
David Hugh Rushton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Scientific Ltd
Original Assignee
Bio Scientific Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Scientific Ltd filed Critical Bio Scientific Ltd
Application granted granted Critical
Publication of ES2185942T3 publication Critical patent/ES2185942T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

SE EXPONE EL USO DE LA L - LISINA EN LA FABRICACION DE UN MEDICAMENTO PARA LA PROFILAXIS Y TRATAMIENTO DE LA CAIDA DEL CABELLO EN LOS HUMANOS, PARTICULARMENTE DEL EFLUVIO DE TELOGENO. SE PROPORCIONA TAMBIEN UN KIT QUE INCLUYE UNA SERIE DE RECIPIENTES SEPARADOS, CADA UNO DE LOS CUALES CONTIENE AL MENOS UN AGENTE ACTIVO, UTIL EN UNA TERAPIA COMBINADA PARA EL TRATAMIENTO DE LA CAIDA GENETICA DEL CABELLO, CARACTERIZADO PORQUE DICHO KIT INCLUYE L - LISINA Y AL MENOS OTRO AGENTE ACTIVO SELECCIONADO ENTRE EL MINOXIDILO, ANTI - ANDROGENOS, INHIBIDORES DE LA 5 AL - REDUCTASA, INHIBIDORES DE LA AROMATASA Y CORTICOSTEROIDES.
ES97925169T 1996-06-10 1997-06-06 Uso de la l-lisina en el tratamiento de la perdida del cabello. Expired - Lifetime ES2185942T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9612108A GB2314019B (en) 1996-06-10 1996-06-10 The use of L-Lysine in the treatment of hair loss

Publications (1)

Publication Number Publication Date
ES2185942T3 true ES2185942T3 (es) 2003-05-01

Family

ID=10795046

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97925169T Expired - Lifetime ES2185942T3 (es) 1996-06-10 1997-06-06 Uso de la l-lisina en el tratamiento de la perdida del cabello.

Country Status (14)

Country Link
US (1) US6136860A (es)
EP (1) EP0914078B1 (es)
JP (1) JP2000511876A (es)
AT (1) ATE226058T1 (es)
AU (1) AU721751B2 (es)
CA (1) CA2257607C (es)
DE (1) DE69716434T2 (es)
DK (1) DK0914078T3 (es)
ES (1) ES2185942T3 (es)
GB (1) GB2314019B (es)
HK (1) HK1019552A1 (es)
NZ (1) NZ333108A (es)
PT (1) PT914078E (es)
WO (1) WO1997047276A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1773600A (en) * 1998-12-21 2000-07-12 Aps Kbus 8 Nr. 4788 Topical treatment of skin disease
DE19957710A1 (de) * 1999-11-30 2001-05-31 Asat Ag Applied Science & Tech Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
US6596266B2 (en) 2000-02-18 2003-07-22 Natural Science, Inc. Compositions containing minoxidil and saw palmetto for treating baldness
WO2002094256A1 (en) * 2001-05-23 2002-11-28 Debatosh Datta Lysine and/or analogues and/or polymers thereof for promoting wound healing and angiogenesis
ITMI20011732A1 (it) * 2001-08-07 2003-02-07 Indena Spa Composizioni farmaceutiche e/o cosmetiche orali per il trattamento e la prevenzione di disturbi del cuoio capelluto
WO2005105022A1 (ja) 2004-04-28 2005-11-10 Yoshiyasu Ito 育毛剤
WO2006091587A2 (en) * 2005-02-22 2006-08-31 Cedars-Sinai Medical Center Use of minoxidil sulfate as an anti-tumor drug
JP5315992B2 (ja) * 2006-06-08 2013-10-16 味の素株式会社 育毛用組成物
DE102008012988A1 (de) 2008-03-07 2009-09-10 S.W. Patentverwertungs Ltd. Zusammensetzung und Verwendungen zur Beeinflussung des Haarwachstums
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
KR20240011239A (ko) * 2014-10-29 2024-01-25 삼손 클리니컬 피티와이 엘티디 과도한 모발 쉐딩의 검출 및 치료
EP3175837A1 (en) 2015-12-01 2017-06-07 Noxell Corporation Method for treating hair
ES2725009T3 (es) * 2016-03-04 2019-09-18 Laboratorio Reig Jofre S A Comprimidos con un alto contenido de principios activos útiles para el tratamiento de la pérdida de cabello o la estimulación de su crecimiento
US20190269684A1 (en) * 2017-07-12 2019-09-05 Samson Clinical Pty Ltd Promoting hair growth and treatment of hair loss or excessive hair shedding

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB720561A (en) * 1952-04-17 1954-12-22 Frederick Victor Wells Improvements in preparations for application to the hair and scalp
LU54223A1 (es) * 1967-08-01 1969-03-24
BE789856A (fr) * 1971-10-13 1973-02-01 Tixier Georges Medicament a base de derives de la lysine susceptibles de stimuler differents metabolismes, en particulier la genese des leucocytes
DE3118882C2 (de) * 1981-05-13 1985-11-14 Rudolf V. Dr.rer.nat Dipl.-Chem. 5024 Pulheim Noronha Mittel gegen Haarausfall und zur Förderung des Haarwuchs
JPS60142908A (ja) * 1983-12-29 1985-07-29 Kanebo Ltd 養毛化粧料
ATE89159T1 (de) * 1985-07-18 1993-05-15 Peter H Proctor Topische zusammensetzung und verfahren zur anregung des haarwuchses.
US5470876A (en) * 1985-07-18 1995-11-28 Proctor; Peter H. Topical sod for treating hair loss
DE68917946T2 (de) * 1988-01-29 1995-01-05 Peter H Proctor Haarwachstumanregung mit Nitroxyd und anderen Radikalen.
FR2609393A1 (fr) * 1988-02-23 1988-07-15 Serobiologiques Lab Sa Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques comprenant une substance azotee, notamment aminoacides, oligo- ou polypeptides, proteines, et leurs derives, et composition pharmaceutique ou cosmetique ainsi preparee.
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
US5133958A (en) * 1989-04-20 1992-07-28 Erwin Stuckler Agent for nail, skin and hair care
US5122369A (en) * 1990-03-30 1992-06-16 Harmony Health Products, Inc. Nutrient composition for preventing hair loss
FR2669224B1 (fr) * 1990-11-15 1995-04-28 Marcel Contier Compositions capillaires, destinees notamment a la neutralisation de l'acide lactique du cuir chevelu et methode de traitement cosmetique du cuir chevelu.
GB9210768D0 (en) * 1992-05-20 1992-07-08 Unilever Plc Cosmetic composition
DE19520662A1 (de) * 1995-06-07 1996-12-12 Beiersdorf Ag Mittel zur Behandlung von Kopfschuppen und zur Behandlung der Haare

Also Published As

Publication number Publication date
EP0914078B1 (en) 2002-10-16
DK0914078T3 (da) 2003-02-17
JP2000511876A (ja) 2000-09-12
AU721751B2 (en) 2000-07-13
NZ333108A (en) 2000-05-26
GB2314019A8 (en) 1998-03-30
GB9612108D0 (en) 1996-08-14
AU3040497A (en) 1998-01-07
DE69716434D1 (de) 2002-11-21
ATE226058T1 (de) 2002-11-15
US6136860A (en) 2000-10-24
GB2314019A (en) 1997-12-17
PT914078E (pt) 2003-02-28
CA2257607C (en) 2010-11-02
HK1019552A1 (en) 2000-02-18
EP0914078A1 (en) 1999-05-12
DE69716434T2 (de) 2003-06-18
CA2257607A1 (en) 1997-12-18
WO1997047276A1 (en) 1997-12-18
GB2314019B (en) 2000-03-15

Similar Documents

Publication Publication Date Title
ES2185942T3 (es) Uso de la l-lisina en el tratamiento de la perdida del cabello.
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
NO975716L (no) Imidazolforbindelser
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
MX9707570A (es) Utilizacion de agonistas de alta1l para el tratamiento de la incontinencia urinaria.
EP0681831A3 (fr) Utilisation d'extraits de bactéries filamenteuses comme agents cosmétiques contre le vieillissement cutané.
ES2148550T3 (es) Composicion de tinte para el cabello.
BR0317461A (pt) Composições tópicas absorventes de óleo e método para o uso das mesmas
SE9402880D0 (sv) New peptide derivatives
ES2100680T3 (es) Composicion para el tratamiento del cabello.
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
IL102344A0 (en) Method of preventing and treating chemotherapy-induced alopecia
ES2157984T3 (es) Utilizacion de 4'-yodo-4'-desoxidoxorrubicina para el tratamiento de la amidoidosis.
DE3674971D1 (en) P-acylaminobenzamide.
GR3023486T3 (en) Use of hydroxynaphthalenes in colouring agents
ATE157532T1 (de) Färbemittel mit tetraaminopyrimidin und direktziehern
AR006437A1 (es) Uso de monohidrocloruro de n-(endo-9-metil-9-azabiciclo [3.3.1]non-3-il)-1- metilimidazol-3-carboxamida, para la fabricacion de un medicamento para eltratamiento o la profilaxis de diarrea y una composicion farmaceutica que lo contiene
IT1286620B1 (it) Macchina per trattamenti di concia e simili